| Literature DB >> 27449012 |
Warunee Thienkrua1, Catherine S Todd2, Wannee Chonwattana1, Wipas Wimonsate1, Supaporn Chaikummao1, Anchalee Varangrat1, Anupong Chitwarakorn3, Frits van Griensven4,5, Timothy H Holtz1,6.
Abstract
BACKGROUND: High HIV incidence has been detected among men who have sex with men (MSM) in Thailand, but the relationship and timing of HIV, herpes simplex virus 2 (HSV-2), and syphilis is unknown. This analysis measures incidence, temporal relationships, and risk factors for HIV, HSV-2, and syphilis among at-risk MSM in the Bangkok MSM Cohort Study.Entities:
Keywords: HIV incidence; HSV-2 incidence; Men who have sex with men; Syphilis incidence; Thailand
Mesh:
Year: 2016 PMID: 27449012 PMCID: PMC4957431 DOI: 10.1186/s12879-016-1667-z
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Comparison of baseline characteristics of men who have sex by infection status at cohort entry in Bangkok, Thailand, 2006–2012 (n = 960)
| Characteristic | Uninfecteda group ( | Remainder of cohort ( |
|
|---|---|---|---|
| n, % | n, % | ||
| Age (years): | 0.72 | ||
| 18–21 | 170, 17.7 % | 144, 18.4 % | |
| 22–29 | 523, 54.5 % | 412, 52. 6 % | |
| ≥30 | 267, 27.8 % | 228, 29.1 % | |
| Education: | <0.01 | ||
| Primary | 11, 1.1 % | 47, 6.0 % | |
| Secondary/Vocational | 457, 47.6 % | 469, 59.8 % | |
| University or higher | 492, 51.3 % | 268, 34.2 % | |
| Study/Work Status: | <0.01 | ||
| Studying (or studying and employed) | 380, 39.6 % | 250, 31.9 % | |
| Employed | 545, 56.8 % | 491, 62.6 % | |
| Unemployed | 35, 3.6 % | 43, 5.5 % | |
| Living Situation: | <0.01 | ||
| With family | 413, 43.0 % | 246, 31.4 % | |
| With partner | 128, 13.3 % | 133, 17.0 % | |
| Alone/with roommate | 419, 43.6 % | 405, 51.7 % | |
| Sexual Identity: | 0.44 | ||
| Homosexual | 741, 77.2 % | 615, 78.4 % | |
| Bisexual | 211, 22.0 % | 158, 20.2 % | |
| Transgender | 8, 0.8 % | 11, 1.4 % | |
| Binge drinking | 92, 9.6 % | 116, 14.8 % | <0.01 |
| Use club drugsb,c | 178, 18.5 % | 191, 24.4 % | <0.01 |
| Use nitrate inhalantsc | 152, 15.8 % | 168, 21.4 % | <0.01 |
| Use drugs to enhance sexc | 135, 14.1 % | 171, 21.8 % | <0.01 |
| Use erectile dysfunction drugsc | 96, 10.0 % | 106, 13.5 % | 0.02 |
| Engage in group sexc | 320, 33.3 % | 301, 38.4 % | 0.03 |
| Coerced into sexc | 155, 16.1 % | 146, 18.6 % | 0.17 |
| Pay for sexc | 140, 14.6 % | 114, 14.5 % | 0.98 |
| Receive money for sexc | 147, 15.3 % | 187, 23.9 % | <0.01 |
| Casual male partners:c | 0.02 | ||
| 0–2 | 389, 40.5 % | 274, 34.9 % | |
| ≥3 | 571, 59.5 % | 510, 65.1 % | |
| Condom use with casual male partners:c | <0.01 | ||
| Consistent (always) | 444, 46.3 % | 349, 44.5 % | |
| Sometimes | 203, 21.1 % | 221, 28.2 % | |
| Never | 44, 4.6 % | 22, 2.8 % | |
| No anal intercourse | 269, 28.0 % | 192, 24.5 % |
aHIV, herpes simplex-2 virus, and syphilis
bClub drugs include cannabis, 3,4-methylenedioxy-N-methylamphetamine (MDMA or ecstasy), amphetamine, methamphetamine, ketamine, cocaine, and gamma hydroxy butyrate (GHB)
cIn the last four months from time of enrollment
Fig. 1Comparison of time to infection between HSV-2, HIV, and syphilis among a cohort of men who have sex with men in Bangkok, Thailand, 2006–2012 (n = 960)
Factors predictive of HIV, herpes simplex virus 2 (HSV-2), and syphilis acquisition among serologically-negative MSM in Bangkok, Thailand (2006–2012)
| HIV ( | HSV-2 ( | Syphilis ( | ||||
|---|---|---|---|---|---|---|
| Factors | HR (95 % CI)b | AHR (95 % CI) | HR (95 % CI) | AHR (95 % CI) | HR (95 % CI) | AHR (95 % CI) |
| Age | 0.92, 0.89–0.95 | 0.94, 0.91–0.97 | 0.97, 0.94–1.01 | 0.96, 0.90–1.01 | ||
| Current living situation | ||||||
| With family | Reference | Reference | Reference | |||
| With partner | 1.25, 0.77–2.05 | 1.23, 0.72–2.12 | 1.86, 0.95–3.66 | |||
| Alone/with roommate | 1.52, 1.09–2.13 | 1.26, 0.87–1.84 | 1.20, 0.70–2.07 | |||
| Sexual debut ≥18 years | ||||||
| Yes | 0.62, 0.45–0.85 | 0.63, 0.44–0.90 | 0.69, 0.41–1.14 | |||
| No | Reference | Reference | Reference | |||
| Usual sexual position | ||||||
| Insertive | Reference | Reference | Reference | |||
| Receptive/versatile | 1.72, 1.23–2.40 | 0.94, 0.66–1.33 | 1.01, 0.62–1.67 | |||
| Ever coerced into sex | ||||||
| Yes | 0.67, 0.47–0.97 | 0.89, 0.58–1.38 | 0.63, 0.36–1.12 | |||
| No | Reference | Reference | Reference | |||
| Risk behaviors in the last 12 months: | ||||||
| Used Ecstasy | ||||||
| Yes | 2.00, 1.11–3.61 | 1.87, 0.97–3.60 | 1.83, 0.66–5.08 | |||
| No | Reference | Reference | Reference | |||
| Used nitrate inhalants (poppers) | ||||||
| Yes | 2.32, 1.48–3.62 | 1.72, 0.99–2.99 | 2.36, 1.16–4.80 | |||
| No | Reference | Reference | Reference | |||
| Used methamphetamine-type stimulants | ||||||
| Yes | 1.71, 1.08–2.72 | 1.73, 1.04–2.89 | 2.26, 1.18–4.33 | |||
| No | Reference | Reference | Reference | |||
| Used drugs to enhance sex | ||||||
| Yes | 1.68, 1.14–2.47 | 1.54, 0.99–2.40 | 2.27, 1.28–4.03 | 1.85, 1.03–3.33 | ||
| No | Reference | Reference | Reference | |||
| Receptive anal intercourse | ||||||
| Yes | 5.70, 3.09–10.5 | 3.10, 1.66–5.79 | 1.99, 1.24–3.20 | 1.99, 1.04–3.82 | ||
| No | Reference | Reference | Reference | |||
| Cleansing after anal intercourse | ||||||
| Yes | 0.77, 0.70–0.85 | 0.88, 0.79–0.97 | 0.95, 0.87–1.03 | 0.94, 0.84–1.05 | ||
| No | Reference | Reference | Reference | |||
| Had >1 steady partner | ||||||
| Yes | 1.38, 0.94–2.04 | 2.32, 1.35–3.99 | 2.74, 1.31–5.71 | 2.10, 1.00–4.41 | ||
| No | Reference | Reference | Reference | |||
| Casual partner: | ||||||
| 0 partner | Reference | Reference | Reference | |||
| 1 partner | 1.42, 0.64–3.18 | 1.95, 0.92–4.16 | 1.44, 0.57–3.64 | |||
| 2–4 partners | 2.48, 1.41–4.34 | 1.31, 0.69–2.47 | 1.33, 0.64–2.77 | |||
| 5–7 partners | 2.56, 1.42–4.64 | 1.58, 0.83–3.02 | 1.06, 0.45–2.47 | |||
| 8–14 partners | 2.62, 1.48–4.64 | 1.84, 1.01–3.33 | 1.46, 0.70–3.03 | |||
| Had transgender partner | ||||||
| Yes | 0.76, 0.34–1.71 | 2.11, 1.16–3.83 | 2.07, 1.13–3.77 | 0.32, 0.04–2.32 | ||
| No | Reference | Reference | Reference | |||
| Had group sex | ||||||
| Yes | 1.87, 1.36–2.57 | 1.51, 1.08–2.10 | 1.38, 0.95–2.00 | 1.20, 0.70–2.07 | ||
| No | Reference | Reference | Reference | |||
| Was paid for sex | ||||||
| Yes | 1.20, 0.78–1.82 | 1.71, 1.12–2.63 | 1.83, 0.96–3.51 | |||
| No | Reference | Reference | Reference | |||
| Consistent condom use: | ||||||
| With steady partner(s) | ||||||
| Yes | 0.79, 0.57–1.10 | 1.00, 0.70–1.44 | 1.37, 1.04–1.82 | |||
| No | Reference | Reference | Reference | |||
| With casual partner(s) | ||||||
| Yes | 1.11, 0.94–1.31 | 1.19, 0.96–1.48 | 0.85, 0.66–1.11 | |||
| No | Reference | Reference | Reference | |||
| With paid partner (s) | ||||||
| Yes | 0.79, 0.61–1.03 | 1.04, 0.81–1.33 | 0.38, 0.17–0.88 | 0.40, 0.17–0.96 | ||
| No | Reference | Reference | Reference | |||
| With client partner(s) | ||||||
| Yes | 1.04, 0.83–1.32 | 1.31, 1.04–1.65 | 1.34, 0.94–1.89 | |||
| No | Reference | Reference | Reference | |||
| Places meet partners: | ||||||
| On the internet | ||||||
| Yes | 1.80, 1.27–2.56 | 1.56, 1.11–2.19 | 1.68, 1.13–2.52 | 0.93, 0.54–1.62 | ||
| No | Reference | Reference | Reference | |||
| Sauna | ||||||
| Yes | 1.79, 1.35–2.38 | 1.32, 0.90–1.95 | 0.78, 0.46–1.36 | |||
| No | Reference | Reference | Reference | |||
| Disco | ||||||
| Yes | 1.95, 1.47–2.57 | 1.50, 1.03–2.20 | 1.02, 0.57–1.82 | |||
| No | Reference | Reference | Reference | |||
| Places for casual sex: | ||||||
| Sauna | ||||||
| Yes | 1.66, 1.22–2.26 | 1.58, 1.12–2.23 | 1.64, 1.14–2.34 | 0.80, 0.48–1.32 | ||
| No | Reference | Reference | Reference | |||
| Hotel | ||||||
| Yes | 1.18, 0.85–1.64 | 1.51, 1.05–2.16 | 1.45, 0.87–2.39 | |||
| No | Reference | Reference | Reference | |||
| Own home | ||||||
| Yes | 1.83, 1.34–2.50 | 1.77, 1.24–2.53 | 1.48, 1.05–2.10 | 0.89, 0.53–1.47 | ||
| No | Reference | Reference | Reference | |||
| Partner’s home | ||||||
| Yes | 1.87, 1.34–2.61 | 1.39, 0.97–1.98 | 1.13, 0.69–1.83 | |||
| No | Reference | Reference | Reference | |||
| Anal discharge | ||||||
| Yes | 5.66, 2.31–13.9 | 4.05, 1.65–9.95 | 4.57, 1.67–12.5 | 3.53, 0.49–25.3 | ||
| No | Reference | Reference | Reference | |||
| Diagnosed with STI | ||||||
| Yes | 1.39, 0.83–2.33 | 2.32, 1.47–3.64 | 1.72, 1.09–2.70 | 4.16, 2.31–7.49 | 2.73, 1.43–5.22 | |
| No | Reference | Reference | Reference | |||
| Incident syphilis | ||||||
| Yes | 3.54, 1.97–6.36 | 3.16, 1.73–5.76 | 4.86, 2.69–8.78 | 3.49, 1.89–6.42 | N/A | |
| No | Reference | Reference | Reference | |||
| Incident HSV-2 | ||||||
| Yes | 1.84, 1.18–2.88 | N/A | 3.05, 1.80–5.18 | 1.93, 1.11–3.36 | ||
| No | Reference | Reference | Reference | |||
| Incident HIV | ||||||
| Yes | N/A | 2.59, 1.69–3.95 | 2.26, 1.47–3.48 | 6.03, 3.75–9.69 | 4.41, 2.65–7.35 | |
| No | Reference | Reference | Reference | |||
| Prevalent HSV-1 | ||||||
| Yes | 0.70, 0.51–0.96 | 0.73, 0.53–0.99 | 1.49, 1.06–2.08 | 1.69, 1.20–2.39 | 0.74, 0.46–1.20 | |
| No | Reference | Reference | Reference | |||
AHR adjusted hazard ratio
CI confidence interval
HIV human immunodeficiency virus
HR hazard ratio
HSV-1 herpes simplex virus 1
HSV-2 herpes simplex virus 2
STI sexually transmitted infection
aNumber of participants varies between infections based on the number contributing follow-up data with at least one follow-up test
bOnly factors significant at p < 0.10 are shown in the HR columns, and only factors significant at p < 0.05 are shown in the AHR columns